Group 2G: Metastatic Breast Cancer; Brain Metastases; Biomarkers; Novel Drug

Name: Group 2G: Metastatic Breast Cancer; Brain Metastases; Biomarkers; Novel Drug
Start: 2024-12-17
End: 2024-12-17

Poster #P1-02-26: Biomarkers in metastatic breast cancer with brain metastases – a subanalysis of matched tumor samples of the BMBC registry

Poster #P3-09-29: A Novel BBB-permeable Agent for Breast Cancer Brain Metastases